Cargando…

Setting of an import tolerance for chlorantraniliprole in hops

In accordance with Article 6 of Regulation (EC) No 396/2005, the applicant DuPont de Nemours (Deutschland) GmbH submitted a request to the competent national authority in France to set an import tolerance for the active substance chlorantraniliprole in hops. The data submitted in support of the requ...

Descripción completa

Detalles Bibliográficos
Autores principales: Brancato, Alba, Brocca, Daniela, Carrasco Cabrera, Luis, De Lentdecker, Chloe, Erdos, Zoltan, Ferreira, Lucien, Greco, Luna, Jarrah, Samira, Kardassi, Dimitra, Leuschner, Renata, Lythgo, Christopher, Medina, Paula, Miron, Ileana, Molnar, Tunde, Pedersen, Ragnor, Reich, Hermine, Riemenschneider, Christina, Sacchi, Angela, Santos, Miguel, Stanek, Alois, Sturma, Juergen, Tarazona, Jose, Theobald, Anne, Vagenende, Benedicte, Villamar‐Bouza, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7009667/
https://www.ncbi.nlm.nih.gov/pubmed/32625945
http://dx.doi.org/10.2903/j.efsa.2018.5312
Descripción
Sumario:In accordance with Article 6 of Regulation (EC) No 396/2005, the applicant DuPont de Nemours (Deutschland) GmbH submitted a request to the competent national authority in France to set an import tolerance for the active substance chlorantraniliprole in hops. The data submitted in support of the request were found to be sufficient to derive an maximum residue level (MRL) proposal for hops in support of the authorised use in the USA. Adequate analytical methods for enforcement are available to control the residues of chlorantraniliprole in hops at the validated limit of quantification (LOQ) of 0.01 mg/kg. Based on the risk assessment results, EFSA concluded that the long‐term intake of residues resulting from the existing uses and the authorised use of chlorantraniliprole according to the reported agricultural practice is unlikely to present a risk to consumer health. The reliable end points, appropriate for use in regulatory risk assessment are presented.